The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma
CompletedOBSERVATIONAL
Enrollment
250
Participants
Timeline
Start Date
February 10, 2021
Primary Completion Date
April 30, 2023
Study Completion Date
April 30, 2023
Conditions
Diffuse Large B Cell LymphomaPatient Reported Outcome
Interventions
OTHER
No intervention
No intervention
Trial Locations (1)
2100
Therese Lassen, Copenhagen
All Listed Sponsors
lead
Herlev Hospital
OTHER
NCT04695366 - The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma | Biotech Hunter | Biotech Hunter